Unknown

Dataset Information

0

Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naive anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: an effective but still broken option.

ABSTRACT:

SUBMITTER: Ricciuti B 

PROVIDER: S-EPMC6987338 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: an effective but still broken option.

Ricciuti Biagio B   Lamberti Giuseppe G   Roila Fausto F   Metro Giulio G  

Translational lung cancer research 20191201 Suppl 4

Similar Datasets

Unknown Anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer.
| S-EPMC8798861 | biostudies-literature
Unknown Anaplastic Lymphoma Kinase (ALK) Receptor Tyrosine Kinase: A Catalytic Receptor with Many Faces.
| S-EPMC6274813 | biostudies-literature
Unknown Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice.
| S-EPMC5045374 | biostudies-literature
Unknown Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor-Associated Cardiotoxicity: A Recent Five-Year Pharmacovigilance Study.
| S-EPMC8968911 | biostudies-literature
Unknown Current Insights on the Treatment of Anaplastic Lymphoma Kinase-Positive Metastatic Non-Small Cell Lung Cancer: Focus on Brigatinib.
| S-EPMC8786362 | biostudies-literature
Unknown Expert consensus of management of adverse drug reactions with anaplastic lymphoma kinase tyrosine kinase inhibitors
| S-EPMC10225873 | biostudies-literature
Unknown Brigatinib Dose Rationale in Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: Exposure-Response Analyses of Pivotal ALTA Study.
| S-EPMC7762810 | biostudies-literature
Unknown Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma.
| S-EPMC5803446 | biostudies-literature
Unknown Safety and efficacy of anaplastic lymphoma kinase tyrosine kinase inhibitors in non‑small cell lung cancer (Review).
| S-EPMC7709813 | biostudies-literature
Unknown A crucial role for the Anaplastic lymphoma kinase receptor tyrosine kinase in gut development in Drosophila melanogaster.
| S-EPMC1326337 | biostudies-literature